comprehensive -WSS

comprehensive

author：leisure time 2025-09-02 11:40:45 - browse：3144

Americans who suffer severe allergic reactions won’t have alternatives to auto-injectors like the EpiPen for a while longer. In a surprise move, the Food and Drug Administration on Tuesday declined to approve neffy, an epinephrine nasal spray. Instead, the FDA asked the drug’s manufacturer, ARS Pharma, to conduct further studies, specifically comparing the effect of repeat doses of epinephrine administered via nasal spray versus auto-injection in people with allergic rhinitis, or hay fever.

This was unexpected, and disappointing, for ARS Pharma: In May, an FDA advisory committee had voted 16-6 in favor of neffy’s approval for adults, and 17-5 in favor for children. But there is at least one party that’s likely to benefit from this development: Viatris, the maker of EpiPen, the brand-name epinephrine auto-injector used to treat anaphylaxis. (A generic version is also available, made by Teva).

In June, Viatris filed a citizen petition with the FDA, saying that the available evidence left doubts about how neffy would actually perform in a real-life anaphylactic event compared to auto-injectable epinephrine.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Does Medicare's free annual wellness visit do any good?

WSS

Eliminate the waiting period for sterilization covered by Medicaid

Jesse Tyler Ferguson makes friendship bracelets for Taylor Swift's Eras Tour

Eat, drink, but be wary — 4 foods that interact with medications

Medical mystery: When an infection after surgery isn’t what it seems

Tuesday set an unofficial record for the hottest day on Earth. Wednesday may break it.

Medical schools are missing the mark on artificial intelligence

hotspot

comprehensive

focus

Drug repurposing or repositioning? The language matters

Abortion pill case raises question: who can sue the FDA?

Trump demands the U.S. pay no more for drugs than other countries … again

Scientists boost immune system in aging mice by making it youthful

In age of alternative facts, a scholarly course on calling out crap

Prosecutors seek bail revocation for FTX founder Sam Bankman

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

There's no autism epidemic. It's an autism diagnosis epidemic

How one medical school became remarkably diverse

Scientists boost immune system in aging mice by making it youthful

Wikipedia

Climate activists disrupt London Pride march to protest corporate sponsorship

Scientists boost immune system in aging mice by making it youthful

Washington mulls new rules to avert another Change Healthcare

Jesse Tyler Ferguson makes friendship bracelets for Taylor Swift's Eras Tour

Tuesday set an unofficial record for the hottest day on Earth. Wednesday may break it.

Covid vaccine financial winners and losers, from Pfizer to Novavax

hotspot

Wikipedia

Wikipedia

hotspot